Getein Biotech,Inc News

Basic Egg Biology (603387): Multi-production line layout and platform-based construction first take shape

申萬宏源研究Jan 5 18:42

Basal Egg Biology (603387): Various product lines have returned to a rapid growth channel, and the results for the first quarter of this year exceeded expectations

長城國瑞證券Apr 29, 2022 00:00

Basal Egg Biology (603387): Performance picked up, and the market for new products reacted positively

長城國瑞證券Aug 19, 2021 00:00

Basic Egg Biology (603387): As the impact of the epidemic gradually weakened, sales gradually picked up, and new products were introduced in an orderly manner to bring new impetus to the market

方正證券Aug 18, 2021 00:00

Basal Egg Biology (603387): Leading domestic POCT companies actively lay out major tests

長城國瑞證券Nov 26, 2020 00:00

Basic egg biology (603387): benefit from the demand of agency business, Q3 revenue doubles, growth, new product promotion will bring more room for growth in the future.

方正證券Oct 27, 2020 00:00

Dynamic review of key egg biology (603387) company: the performance is in line with the expected Q2 revenue month-on-month improvement

川財證券Aug 27, 2020 00:00

Basic egg biology (603387): Q2 hospital-end demand gradually resumes and new products are introduced to the market will drive performance growth

方正證券Aug 26, 2020 00:00

Basic egg biology (603387): POCT helps to promote the strategy of biochemical luminescence in grass-roots medical care.

川財證券Mar 31, 2020 00:00

Comments on the annual report of basic egg biology (603387) 2018: it is worth looking forward to for POCT to maintain high growth and multi-faceted layout.

興業證券Apr 11, 2019 00:00

Key egg biology (603387) annual report review report: performance in line with expectations of new products to promote long-term development

國聯證券Apr 10, 2019 00:00

基蛋生物(603387)深度报告：心血管类POCT领先企业 “试剂+生物原料+仪器”协同发展助高成长

廣證恆生Apr 7, 2019 00:00

Base Egg Biotech (603387) Quarterly Report Review: Costs Drag Down Performance Slightly Lower Expectations for the Third Quarter

國聯證券Oct 30, 2018 00:00

Key Egg Biotech (603387) Third Quarterly Report Review: Steady Performance Growth Established a Subsidiary in India to Improve Overseas Marketing Network Construction

東方財富證券Oct 29, 2018 00:00

BaseEgg Biotech (603387) Quarterly Report Review: Decline in revenue growth in the third quarter continued to increase investment in R&D

財通證券Oct 29, 2018 00:00

Basis Egg Biology (603387) Interim Report Review: Fully Automatic Instruments Drive Revenue Growth Rate Exceeding Expectations

新時代證券Sep 1, 2018 00:00

Basis Egg Biotech (603387) Semi-Annual Report Review: Performance Continues to Grow High, New Products Are Worth Looking forward to

國聯證券Sep 1, 2018 00:00

Basis Egg Biotech (603387) Interim Report Review: Performance Meets Expectations, Cardiovascular POCT Business Continues High Growth Trend

財通證券Sep 1, 2018 00:00

Key Egg Biotech (603387) Interim Report: Rapid growth in performance is optimistic about the company's development

興業證券Aug 31, 2018 00:00

基蛋生物(603387)2018年中报点评：业绩表现靓丽 不断丰富仪器产品线和检测项目

東方財富證券Aug 30, 2018 00:00